Blog 06 Q&A with Erin Connolly-Strong PhD, Head Medical Affairs Scipher Medicine via BiopharmaDive Multiple classes of drugs exist for treating rheumatoid arthritis (RA) patients. But close to 90% of patients failing methotrexate are prescribed the world’s largest...
Expanded intended use for the blood test validated in Network-004 study.Now, most rheumatoid arthritis patients can be tested at any point in their clinical journey.Test enables providers to identify optimal rheumatoid arthritis treatment for more than 600,000...
Blog 4 Researchers at Scipher Medicine have combined proprietary data and artificial intelligence to predict a patient’s response to costly biologics. Slava Akmaev, Ph.D., Scipher Chief Technology Officer and Head of Therapeutics describes the implications of their...
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection JUNE 24, 2021 – WALTHAM, MA – Scipher Medicine, a precision immunology company matching...
Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohortPrismRA demonstrates a more efficient therapy selection protocol beyond current standardThree...
V. Strand, S. Cohen, L. Zhang, T. Mellors, A. Jones, J. Withers, V. Akmaev Annals of the Rheumatic Diseases 2021;80:1097-1098. Abstract: Background: Therapy choice and therapy change depend on the ability to accurately assess patients’ disease activity. The clinical...
L. Zhang1 , C. van der Tog2 , A. den Broeder2 , T. Mellors1 , E. Connolly-Strong1 , J. Withers1 , A. Jones1 , V. Akmaev1 . 1 Scipher Medicine Corporation, Science and Technology, Waltham, United States of America; 2 Sint Maartenskliniek, Department of Rheumatology,...
Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune diseases. June 8, 2021 – WALTHAM, MA – Scipher Medicine, a precision immunology company matching patients with...
– Leverages large genomic database from Scipher’s testing business- Proven SpectraTM platform brings precision therapeutics to autoimmune diseases.- Program commercialized through pharma partnerships. MAY 4, 2021 – WALTHAM, MA – Scipher Medicine, a precision...
Blog 03 Bret S. Stetka, MD Medicine is often a guessing game. Doctors frequently prescribe medications that, while effective across the collective population, may not work for specific individuals. This is why so many clinicians are studying and advocating for...
Deisy Morselli Gysi, Ítalo do Valle, Marinka Zitnik, Asher Ameli, Xiao Gana, Onur Varola, Susan Dina Ghiassian, J. J. Patten, Robert A. Davey, Joseph Loscalzo, and Albert-László Barabási Proceedings of the National Academy of Sciences Abstract: Introduction: The...
-aMoon and Northpond Ventures led the round.-Additional investors include Echo Health Ventures, Khosla Ventures and Alumni Ventures.-Financing will support commercialization of precision medicine PrismTM portfolio of blood tests and data partnerships in autoimmune...
